Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus

NCT02162550 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

148

Enrollment

FED

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Bydureon
DRUG: placebo

Sponsor

Phoenix VA Health Care System